Influenza and pneumonia together account for more than 36,000 deaths and 114,000 hospitalizations annually in the United States. Despite the availability of an excellent healthcare system and effective antimicrobials directed against both influenza and bacterial causes of pneumonia, a substantial number of these deaths are due to secondary bacterial pneumonia. The molecular mechanisms that underlie the interaction between respiratory viruses and bacteria are largely unknown. Since secondary bacterial infections account for a significant proportion of the deaths that occur during circulation of virulent strains, it is critical that we understand the basis of this synergy before the next highly pathogenic influenza virus enters the population from avian sources or as a result of bioterrorism. This application proposes in vitro and in vivo experiments to study this interaction utilizing an animal model of synergism between influenza virus and Streptococcus pneumoniae developed in the laboratory of the Principal Investigator. The main hypotheses that will be tested are that strain-specific influenza virulence factors cause alterations of innate immunity of the host that allow pneumococcal strains expressing particular proteins to survive and produce disease. A detailed understanding of this interaction will provide information important for surveillance and control of influenza viruses, as well as support for drug and vaccine based interventions aimed at amelioration of human disease and death caused by bacterial superinfection following respiratory viral disease. More broadly, the proposed work addresses an interesting biological question, that of polymicrobial interactions, and should serve as a model and stimulus for investigation of the contribution of multiple organisms to other disease states. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI066349-01
Application #
6957297
Study Section
Lung Cellular, Molecular, and Immunobiology Study Section (LCMI)
Program Officer
Lacourciere, Karen A
Project Start
2005-07-01
Project End
2010-03-31
Budget Start
2005-07-01
Budget End
2006-03-31
Support Year
1
Fiscal Year
2005
Total Cost
$318,750
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Samarasinghe, Amali E; Woolard, Stacie N; Boyd, Kelli L et al. (2014) The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Immunol Cell Biol 92:449-59
Wanzeck, Keith; Boyd, Kelli L; McCullers, Jonathan A (2011) Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Am J Respir Crit Care Med 183:767-73
Smith, Amber M; McCullers, Jonathan A; Adler, Frederick R (2011) Mathematical model of a three-stage innate immune response to a pneumococcal lung infection. J Theor Biol 276:106-16
McCullers, Jonathan A (2011) Preventing and treating secondary bacterial infections with antiviral agents. Antivir Ther 16:123-35
Iverson, Amy R; Boyd, Kelli L; McAuley, Julie L et al. (2011) Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 203:880-8
Smith, Amber M; Adler, Frederick R; McAuley, Julie L et al. (2011) Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput Biol 7:e1001081
Alymova, Irina V; Green, Amanda M; van de Velde, Nicholas et al. (2011) Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. J Virol 85:12324-33
McAuley, Julie L; Chipuk, Jerry E; Boyd, Kelli L et al. (2010) PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 6:e1001014
McCullers, Jonathan A; McAuley, Julie L; Browall, Sarah et al. (2010) Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis 202:1287-95
Reichert, Tom; Chowell, Gerardo; Nishiura, Hiroshi et al. (2010) Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 10:5

Showing the most recent 10 out of 31 publications